These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2
6675 results:

  • 1. Genomic Alterations and Clinical Characterization in Chinese Patients with Metastatic colorectal cancer.
    Zhang XH; Zhou JQ; Wei Q; Li J; Xu T; Bai CM; Zhou JF; Wang XC
    Discov Med; 2024 Jul; 36(186):1477-1485. PubMed ID: 39054718
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Targeted panel sequencing of pharmacogenes and oncodrivers in colorectal cancer patients reveals genes with prognostic significance.
    Heczko L; Liška V; Vyčítal O; Fiala O; Šůsová S; Hlaváč V; Souček P
    Hum Genomics; 2024 Jul; 18(1):83. PubMed ID: 39030589
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cribriform morular thyroid carcinoma: Clinicopathological and molecular basis for both a preventive and therapeutic approach for a rare tumor (Review).
    Cameselle-García S; Abdulkader-Nallib I; Sánchez-Ares M; Cameselle-Teijeiro JM
    Oncol Rep; 2024 Sep; 52(3):. PubMed ID: 39027989
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification and validation of calcium extrusion-related genes prognostic signature in colon adenocarcinoma.
    Jin M; Yin C; Yang J; Yang X; Wang J; Zhu J; Yuan J
    PeerJ; 2024; 12():e17582. PubMed ID: 39006025
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy.
    Osumi H; Shinozaki E; Nakamura Y; Esaki T; Yasui H; Taniguchi H; Satake H; Sunakawa Y; Komatsu Y; Kagawa Y; Denda T; Shiozawa M; Satoh T; Nishina T; Goto M; Takahashi N; Kato T; Bando H; Yamaguchi K; Yoshino T
    Nat Commun; 2024 Jul; 15(1):5885. PubMed ID: 39003289
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Epidermal Growth Factor Receptor Targeting in colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance.
    Tardito S; Matis S; Zocchi MR; Benelli R; Poggi A
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000238
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Current and Emerging Treatment Paradigms in colorectal cancer: Integrating Hallmarks of cancer.
    Salva de Torres C; Baraibar I; Saoudi González N; Ros J; Salva F; Rodríguez-Castells M; Alcaraz A; García A; Tabernero J; Élez E
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000083
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dual inhibition of SUMOylation and MEK conquers MYC-expressing kras-mutant cancers by accumulating DNA damage.
    Kotani H; Oshima H; Boucher JC; Yamano T; Sakaguchi H; Sato S; Fukuda K; Nishiyama A; Yamashita K; Ohtsubo K; Takeuchi S; Nishiuchi T; Oshima M; Davila ML; Yano S
    J Biomed Sci; 2024 Jul; 31(1):68. PubMed ID: 38992694
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Inhibition of DUSP18 impairs cholesterol biosynthesis and promotes anti-tumor immunity in colorectal cancer.
    Zhou X; Wang G; Tian C; Du L; Prochownik EV; Li Y
    Nat Commun; 2024 Jul; 15(1):5851. PubMed ID: 38992029
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer.
    Lund-Andersen C; Torgunrud A; Kanduri C; Dagenborg VJ; Frøysnes IS; Larsen MM; Davidson B; Larsen SG; Flatmark K
    J Transl Med; 2024 Jul; 22(1):646. PubMed ID: 38982444
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Biomarker Testing Disparities in Metastatic colorectal cancer.
    Sabbagh S; Herrán M; Hijazi A; Jabbal IS; Mohanna M; Dominguez B; Itani M; Sarna K; Liang H; Nahleh Z; Wexner SD; Nagarajan A
    JAMA Netw Open; 2024 Jul; 7(7):e2419142. PubMed ID: 38967928
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Selective PI3Kδ inhibitor TYM-3-98 suppresses AKT/mTOR/SREBP1-mediated lipogenesis and promotes ferroptosis in kras-mutant colorectal cancer.
    Zheng YN; Lou SY; Lu J; Zheng FL; Tang YM; Zhang EJ; Cui SL; Zhao HJ
    Cell Death Dis; 2024 Jul; 15(7):474. PubMed ID: 38956060
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers and overcomes cancer stemness, trifluridine-induced angiogenesis, ERK1/2 and STAT3 signaling regardless of kras or BRAF mutational status.
    Zhang J; Zhou L; Zhao S; El-Deiry WS
    Oncotarget; 2024 Jul; 15():424-438. PubMed ID: 38953895
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cyclopeptide RA-V from Rubia yunnanensis restores activity of Adagrasib against colorectal cancer by reducing the expression of Nrf2.
    Jiang Z; Ye S; Wu Y; Zhou C; Cao F; Tan N
    Pharmacol Res; 2024 Aug; 206():107252. PubMed ID: 38945380
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. krasFormer: a fully vision transformer-based framework for predicting
    Singh VK; Makhlouf Y; Sarker MMK; Craig S; Baena J; Greene C; Mason L; James JA; Salto-Tellez M; O'Reilly P; Maxwell P
    Biomed Phys Eng Express; 2024 Jul; 10(5):. PubMed ID: 38925106
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Multifaceted effects of LRP6 in cancer: exploring tumor development, immune modulation and targeted therapies.
    Li L; Zhao L; Yang J; Zhou L
    Med Oncol; 2024 Jun; 41(7):180. PubMed ID: 38898247
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis.
    Cohen R; Raeisi M; Chibaudel B; Shi Q; Yoshino T; Zalcberg JR; Adams R; Cremolini C; Van Cutsem E; Heinemann V; Tabernero J; Punt CJA; Arnold D; Hurwitz HI; Douillard JY; Venook AP; Saltz LB; Maughan TS; Kabbinavar F; Bokemeyer C; Grothey A; Mayer RJ; Kaplan R; Tebbutt NC; Randolph Hecht J; Giantonio BJ; Díaz-Rubio E; Sobrero AF; Peeters M; Koopman M; Goldberg RM; Andre T; de Gramont A
    Eur J Cancer; 2024 Aug; 207():114160. PubMed ID: 38896997
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Impact of Oncogenic Changes in p53 and kras on Macropinocytosis and Ferroptosis in Colon cancer Cells and Anticancer Efficacy of Niclosamide with Differential Effects on These Two Processes.
    Nguyen NT; Sennoune SR; Dharmalingam-Nandagopal G; Sivaprakasam S; Bhutia YD; Ganapathy V
    Cells; 2024 May; 13(11):. PubMed ID: 38891084
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Stress-induced Rab11a-exosomes induce amphiregulin-mediated cetuximab resistance in colorectal cancer.
    Mason JD; Marks E; Fan SJ; McCormick K; Wilson C; Harris AL; Hamdy FC; Cunningham C; Goberdhan DCI
    J Extracell Vesicles; 2024 Jun; 13(6):e12465. PubMed ID: 38887984
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Are sporadic colorectal cancers in young patients distinct from those in elderly patients?
    Yang IJ; Kim DW; Lee J; Ahn HM; Oh HK; Kang SB; Suh JW; Kim MH; Oh HJ; Kim HK; Kim MJ; Park JW; Ryoo SB; Park KJ; Jeong SY; Oh JH
    Colorectal Dis; 2024 Jul; 26(7):1405-1414. PubMed ID: 38881232
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 334.